BOSTON, June 18, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, has launched a ...
Haemonetics Corporation HAE recently gained CE mark certification for the VASCADE vascular closure and VASCADE MVP venous vascular closure systems. The VASCADE system is intended for ‘small-bore’ ...
The AMBULATE Same-Day Discharge Clinical Study Series demonstrates safe and effective use of VASCADE MVP in three studies to date, with more than 800 AF ablation patients discharged the same calendar ...
Approval brings proven technology of the MYNX family of products to mid-bore venous puncture sites, including electrophysiology procedures. MIAMI, July 9, 2024 /PRNewswire/ -- Cordis, a global leader ...
WASHINGTON, DC—For vascular closure after transfemoral TAVI, a strategy that combines suture- and plug-based devices halves the risk of access site-related vascular complications during a patient’s’ ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the first patient treated with PerQseal ® ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ® (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced the closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results